LT
Leslie Tari
Chief Scientific Officer

Leslie Tari insider trades: Cidara Therapeutics (CDTX) stock buys and sales

Chief Scientific Officer, Cidara Therapeutics Last trade Mar 11, 2025 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Leslie reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 11, 2025CDTX↓ Sell$39K
Sep 11, 2024CDTX↓ Sell$11K
Mar 11, 2024CDTX↓ Sell$14K
Sep 11, 2023CDTX↓ Sell$18K
Aug 14, 2023CDTX↑ Buy$10K
Mar 13, 2023CDTX↓ Sell$12K
Jan 12, 2023CDTX↓ Sell$14K
Sep 12, 2022CDTX↓ Sell$12K
Jan 5, 2022CDTX↓ Sell$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CDTX insiders

Open-market trades in the last 12 months

About Leslie Tari's insider trades

Leslie Tari is Chief Scientific Officer at Cidara Therapeutics (CDTX). Since Jan 5, 2022, Leslie has reported 1 open-market purchase worth $10K and 8 sales worth $121K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (6 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.